Company
Creo Medical Group PLC
LON:CREO
Creo Medical Group PLC is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue.
113 stories · page 6 of 6
Investments and investor services
FTSE 100 closes in red; IMF cuts UK growth forecasts
The FTSE 100 index closed down 18.87 points at 7,525 on a day of light volumes
Archive
Has Christmas come early for the CBI Distributive Trades Survey?
Last month, the survey reported a pick-up in retail sales following a dip in October, but the report also highlighted the strongest growth in average selling price in over 26 years, highlighting the march of inflation
Archive
Little stuffing for the turkeys in final trading week before Christmas, and beyond
The corporate news diary is, not unsurprisingly, almost completely empty, while the macro calendar is also pretty Spartan aside from two CBI surveys and final UK GDP data
Defenx shares rise as it signs software distribution contract with BV-Tech
A look at the biggest risers and fallers in London today
Sirius Minerals named among the ‘top tips’ for 2017
Here we take a look at the medium and small cap companies included among Fleet Street's top stock market tips for 2017.
Archive
Proactive news round-up: Condor Gold, Metal Tiger, African Potash ...
A glance at today's headlines on the Proactive newswire ...
Creo Medical trades at 6% premium on market debut
In mid-morning trade, shares of the Chepstow-based medical device company were quoted at 80.5p, compared to a flotation price of 76p
Medtech Creo Medical to list on Aim
There's lovely! The Chepstow-based medtech is raising £20mln in fresh capital